- Home
- CHX vs PCVX Comparison
CHX vs PCVX Comparison
Compare CHX & PCVX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CHX
- PCVX
- Stock Information
- Founded
- CHX 1882
- PCVX 2013
- Country
- CHX United States
- PCVX United States
- Employees
- CHX N/A
- PCVX N/A
- Industry
- CHX Industrial Machinery/Components
- PCVX Biotechnology: Pharmaceutical Preparations
- Sector
- CHX Industrials
- PCVX Health Care
- Exchange
- CHX Nasdaq
- PCVX Nasdaq
- Market Cap
- CHX 4.8B
- PCVX 4.5B
- IPO Year
- CHX N/A
- PCVX 2020
- Fundamental
- Price
- CHX $25.10
- PCVX $31.16
- Analyst Decision
- CHX Strong Buy
- PCVX Strong Buy
- Analyst Count
- CHX 3
- PCVX 10
- Target Price
- CHX $37.67
- PCVX $136.50
- AVG Volume (30 Days)
- CHX 4.0M
- PCVX 2.2M
- Earning Date
- CHX 04-29-2025
- PCVX 05-07-2025
- Dividend Yield
- CHX 1.51%
- PCVX N/A
- EPS Growth
- CHX N/A
- PCVX N/A
- EPS
- CHX 1.51
- PCVX N/A
- Revenue
- CHX $3,576,306,000.00
- PCVX N/A
- Revenue This Year
- CHX $5.23
- PCVX N/A
- Revenue Next Year
- CHX $2.20
- PCVX N/A
- P/E Ratio
- CHX $16.63
- PCVX N/A
- Revenue Growth
- CHX N/A
- PCVX N/A
- 52 Week Low
- CHX $21.92
- PCVX $27.66
- 52 Week High
- CHX $35.94
- PCVX $121.06
- Technical
- Relative Strength Index (RSI)
- CHX 47.61
- PCVX 36.73
- Support Level
- CHX $24.09
- PCVX $28.09
- Resistance Level
- CHX $24.95
- PCVX $33.75
- Average True Range (ATR)
- CHX 0.74
- PCVX 2.54
- MACD
- CHX 0.19
- PCVX 1.12
- Stochastic Oscillator
- CHX 72.71
- PCVX 35.61
About CHX ChampionX Corporation
ChampionX provides chemical solutions and equipment for onshore and offshore oil and gas production. Its engineering expertise spans the well lifecycle, but the firm maintains a particular focus on the production phase. Key offerings include artificial lift services and drilling technologies, specializing in polycrystalline diamond cutter inserts. ChampionX was formed after Apergy acquired its chemical technologies business from Ecolab in 2020.
About PCVX Vaxcyte Inc.
Vaxcyte Inc is a clinical-stage vaccine innovation company engineering high-fidelity vaccines to protect humankind from the consequences of bacterial diseases. It is developing broad-spectrum conjugate and novel protein vaccines to prevent or treat bacterial infectious diseases. Its product comprises of Pneumococcal conjugate vaccine. The firm's product candidate consists of VAX-31, VAX-24, VAX-A1, VAX-PG, VAX-GI, and Others.